UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004011
Receipt No. R000004820
Scientific Title Multicenter Phase II sequential study of S-1/Oxaliplatin (SOX) and Bevacizumab as first line therapy followed by S-1/Irinotecan (IRIS) and Cetuximab as second line in patients with metastatic colorectal cancer. : A SOBIC study
Date of disclosure of the study information 2010/08/20
Last modified on 2010/08/06 18:23:08

No. Disposal Last modified on Item of update
1 Insert 2010/08/06 18:10:04
2 Update 2010/08/06 18:23:08 Condition
Condition


Contact us.